FDA

Dr. Kamini Rao Hospitals, an entity under Medline Academics, has officially opened with a primary focus on reproductive medicine and women’s healthcare. Located in Bengaluru, this cutting-edge facility aims to broaden the spectrum of care by catering to all phases […]

In conjunction with the ongoing World Ayurveda Congress (WAC) and Arogya Expo at the Parade Ground in Dehradun, a complimentary Ayush Clinic is offering free medical consultations to the public through the evening of December 15. Operating as a public

A Surge in Innovation: Government Initiatives and Amendments Fuel India’s Patenting Landscape Aligned with India’s governmental priorities and the strategic directions of the Ministry of Industry and Commerce, the Department for Promotion of Industry and Internal Trade (DPIIT) and the

Excipients in tablets and other pharmaceutical formulations play varied roles depending on the intended purpose within the medicine, often necessitating distinct material properties to ensure effective results. The roles of excipients in drugs include facilitating manufacturing, aiding breakdown and absorption

Evolving Landscape of Excipients According to the International Pharmaceuticals Excipients Council, “Pharmaceutical excipients are essentially substances apart from the active pharmaceutical ingredient (API) that are rigorously tested for safety and deliberately incorporated into drug delivery systems to: Facilitate the drug

Despite boasting the globe’s third-largest pharmaceutical industry by volume and leading the production of generic drugs worldwide, India remains significantly reliant on China for sourcing raw materials, Key Starting Materials (KSMs), and Active Pharmaceutical Ingredients (APIs). With India producing approximately

India’s Growth in the Generic Medicine Sector India’s pharmaceutical industry stands as a testament to the country’s significant achievements in both branded and unbranded generic drugs. The pivotal Hathi Commission report of 1969 and the Indian Patents Act of 1970

The Indian pharmaceutical industry continues to garner attention due to its impressive feats in securing regulatory approvals and executing ambitious growth strategies. Industry insiders remain highly encouraged by the sector’s promising trajectory. Recognized for its significant potential in global healthcare,

Dizal, a pioneering biopharmaceutical enterprise focused on creating groundbreaking treatments for cancer and immune system ailments, has announced the release of a comprehensive analysis assessing sunvozertinib’s efficacy in non-small cell lung cancer (NSCLC) patients resistant to epidermal growth factor receptor